NCT01476189View on ClinicalTrials.gov

A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations

PHASE1CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Subjects

Interventions

DRUG

Experimental paracetamol formulation

experimental

DRUG

Marketed paracetamol

Marketed paracetamol

DRUG

Higher dose marketed paracetamol

Higher dose marketed paracetamol

Trial Locations (1)

68501

MDS Pharma Services NEBRASKA, Lincoln

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY